AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Corinna Dan

R.N., M.P.H., Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human Services 

Syringe Services Programs: Requesting a Determination of Need in Consultation with CDC – Webinar.

Corinna Dan - new headshot - April 2016

People who inject drugs (PWID) are at risk for Hepatitis B virus (HBV), Hepatitis C virus (HCV), and HIV infection through the sharing of needles and drug-preparation equipment. The risk of getting and transmitting HIV, viral hepatitis, and other blood-borne infections can be substantially reduced by using a sterile needle and syringe for every injection….

Engaging Faith-Based Groups to Address Viral Hepatitis—Archived Webinar Materials Now Available!

The Partnership Center

Hepatitis B and C affect as many as 2.2 million and 5.3 million people, respectively, from all walks of life and across the United States.  To be successful, our national response to viral hepatitis requires that all parts of society participate, including faith communities.  Recently, the Department of Health and Human Services (HHS) Office of…

Report Concludes Elimination of Hepatitis B & C in U.S. Feasible

Viral Hep blog April 12 - HepBCphase1_highrescover

Yesterday the National Academies of Sciences, Engineering and Medicine released Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report , which affirms that it would be possible to eliminate hepatitis in the U.S. with the right resources, commitment, and strategy. Importantly, the report also concluded that in the…

Federal Work Group Looks to Future of Viral Hepatitis Action Plan

Federal Viral Hepatitis Leadership group - March 2016

Viral hepatitis is a growing public health problem in the United States. This increase is being fueled in part by the widespread epidemic of opioid abuse that is devastating families and communities across the country. These new cases add to the millions of people who are already living with viral hepatitis, many of whom have…

Institute of Medicine Expert Committee Assessing Feasibility of Viral Hepatitis Elimination Targets in the U.S.

Corinna Dan

In 2014, the World Health Organization’s (WHO) World Health Assembly unanimously adopted resolution WHA67.6, [PDF 152 KB] which urged Member States and the WHO Director-General to enhance efforts in viral hepatitis surveillance, prevention, treatment access, and disease control. This resolution tasked the WHO with assessing the feasibility of elimination targets for hepatitis B (HBV) and…

Register Today for Webinar on Viral Hepatitis: Opportunities for Faith-based Groups

hv_map

The HHS Center for Faith-based and Neighborhood Partnerships (Partnership Center) and the Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) have re-scheduled their co-sponsored webinar on the important role of faith communities in the national response to viral hepatitis.  The webinar will introduce a new resource for faith-based groups, the Health Ministers Guide to Viral Hepatitis:…

Register Today for Webinar on Viral Hepatitis: Opportunities for Faith-based Groups

hv_map

NOTE: This webinar has been postponed. Watch this blog for an update on the new date and time. The HHS Center for Faith-based and Neighborhood Partnerships (Partnership Center) and the Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) are co-sponsoring a webinar before the open enrollment period for 2016 coverage from the Health Insurance Marketplace closes…

Updated Expert Guidance on the Management of Chronic Hepatitis B Now Available

aasld-primary-logo-resized

In November 2015, the American Association for the Study of Liver Diseases (AASLD) released updated guidelines for the treatment of chronic hepatitis B infection. Developed and disseminated by AASLD, a professional society of scientists and health care professionals committed to preventing and curing liver disease, the new guidelines are an important tool to support clinical…